News
Lung cancer patients could be denied breakthrough drug because it...
www.manchestereveningnews.co.uk
Nivolumab, which was trialled at The Christie, can almost double survival rates in patients with a form of advanced lung cancer
Tumour shrinking drug is too expensive for NHS | The Times
www.thetimes.co.uk
Nivolumab almost doubled survival rates for the most common type of lung cancer but has been rejected as too costly for routine care
Breathlessness lung disease warning - BBC News
www.bbc.com
Public Health England urges people to seek medical help for persistent coughs or breathlessness in a new campaign aimed at raising awareness of lung cancer and...
Cancer drug nivolumab that double life expectancy delayed by NHS...
www.express.co.uk
A MIRACLE new cancer drug that could DOUBLE the life expectancy of some sufferers is being withheld - because of NHS red tape and MPs' long summer break.
sorted by relevance / date